Clinical characteristics of children with multisystemic inflammatory syndrome associated with COVID-19 Clinical characteristics of MIS-C associated with COVID-19
Annals of Clinical and Analytical Medicine
; 13(1):6-10, 2022.
Статья
в английский
| EMBASE | ID: covidwho-20232186
ABSTRACT
Aim:
Coronavirus disease 2019 (COVID-19) has become a public health threat to people all over the world in 2020 and 2021. The Centers for Disease Control and Prevention (CDC) and WHO (World Health Organization) have named a novel disease multisystem inflammatory syndrome in children (MIS-C). Herein we aimed to present a group of pediatric patients with MIS-C, who were followed up in our clinic. Material(s) and Method(s) We retrospectively reviewed the medical records of patients who were followed up at our University Hospital with the diagnosis of MIS-C between January 2021 and May 2021. Result(s) The mean age of 9 patients was 87.4 +/-17.8 years (range 6-161 months);six of the patients were male. All patients had fever at admission. The duration of the fever was between 3 and 7 days. Four patients (44.4%) had terminal ileitis on ultrasonic examination. The laboratory tests of the patients revealed leukocytosis in 4 (44.4%) patients, anemia in 5 (55.5%) patients, thrombocytopenia in 1 (11.1%) patient, and a high CRP level in 8 (88.8%) patients. All patients had high sedimentation rates and procalcitonin levels. One (11.1%) patient was operated on for terminal ileitis. All patients were treated with steroids (1-2 mg/kg prednisolone) and IVIG (2gr/kg). Patients who needed ICU admission were also treated with vasoactive drug infusion (intravenous dopamine). Discussion(s) There is a need for increased awareness among pediatricians that MIS-C should come to mind, especially in patients with long-lasting fever and signs and symptoms that resemble Kawasaki disease.Copyright © 2022, Derman Medical Publishing. All rights reserved.
Children; covid-19; Hyperinflammation; Intensive Care; Multisystem Inflammatory Syndrome; Steroid; abdominal pain; anemia; arthralgia; arthritis; article; child; clinical article; conjunctivitis; convulsion; coronavirus disease 2019/dt [Drug Therapy]; echography; erythrocyte sedimentation rate; female; fever; headache; hemiparesis; human; hypotension; ileitis; infant; leukocytosis; lymphocytopenia; male; pediatric multisystem inflammatory syndrome/dt [Drug Therapy]; public health; rash; respiratory distress; retrospective study; somnolence; C reactive protein/ec [Endogenous Compound]; dopamine/dt [Drug Therapy]; dopamine/pv [Special Situation for Pharmacovigilance]; fibrinogen/ec [Endogenous Compound]; immunoglobulin/dt [Drug Therapy]; immunoglobulin/iv [Intravenous Drug Administration]; immunoglobulin/pv [Special Situation for Pharmacovigilance]; prednisolone/dt [Drug Therapy]; prednisolone/pv [Special Situation for Pharmacovigilance]; procalcitonin/ec [Endogenous Compound]; steroid/dt [Drug Therapy]; steroid/pv [Special Situation for Pharmacovigilance]
Полный текст:
Имеется в наличии
Коллекция:
Базы данных международных организаций
база данных:
EMBASE
Тип исследования:
Прогностическое исследование
Темы:
Длинный Ковид
Язык:
английский
Журнал:
Annals of Clinical and Analytical Medicine
Год:
2022
Тип:
Статья
Документы, близкие по теме
MEDLINE
...
LILACS
LIS